Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice

Neuroscience

Volumn 183, Issue , 2011, Pages 134-143

  De La Herran Arita A K ^a   Zomosa Signoret, V C ^b   Millan Aldaco D A ^a   Palomero Rivero, M ^a   Guerra Crespo, M ^a   Drucker Colin R ^a   Vidaltamayo, R ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

CNS development; Hypothalamus; Sleep; Transcription factors

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; OREXIN; OREXIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATAPLEXY; CELL DENSITY; CONTROLLED STUDY; DELTA RHYTHM; DOWN REGULATION; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; GENOTYPE; HETEROZYGOSITY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NARCOLEPSY; NERVE FIBER; NERVE PROJECTION; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PONS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REM SLEEP; SEQUENCE ALIGNMENT; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; AROUSAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; CATALEPSY; CELL COUNT; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GENE EXPRESSION REGULATION; GUINEA PIGS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NARCOLEPSY; NEURONS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; TRANS-ACTIVATORS;

EID: 79955611763     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.029     Document Type: Article

References (44)

1. Bally-Cuif L., Dubois L., Vincent A. Molecular cloning of Zcoe2, the zebrafish homolog of Xenopus Xcoe2 and mouse EBF-2, and its expression during primary neurogenesis. Mech Dev 1998, 77:85-90.
2. Beuckmann C.T., Sinton C.M., Williams S.C., Richardson J.A., Hammer R.E., Sakurai T., Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004, 24:4469-4477.
3. Broberger C., De Lecea L., Sutcliffe J.G., Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 1998, 402:460-474.
4. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
5. Chung S.H., Marzban H., Croci L., Consalez G.G., Hawkes R. Purkinje cell subtype specification in the cerebellar cortex: early B-cell factor 2 acts to repress the zebrin II-positive Purkinje cell phenotype. Neuroscience 2008, 153:721-732.
6. Corradi A., Croci L., Broccoli V., Zecchini S., Previtali S., Wurst W., Amadio S., Maggi R., Quattrini A., Consalez G.G. Hypogonadotropic hypogonadism and peripheral neuropathy in Ebf2-null mice. Development 2003, 130:401-410.
7. Croci L., Chung S.H., Masserdotti G., Gianola S., Bizzoca A., Gennarini G., Corradi A., Rossi F., Hawkes R., Consalez G.G. A key role for the HLH transcription factor EBF2, COE2, O/E-3 in Purkinje neuron migration and cerebellar cortical topography. Development 2006, 133:2719-2729.
8. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999, 96:748-753.
9. Datta S., Patterson E.H., Spoley E.E. Excitation of the pedunculopontine tegmental NMDA receptors induces wakefulness and cortical activation in the rat. J Neurosci Res 2001, 66:109-116.
10. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
11. Garcia-Dominguez M., Poquet C., Garel S., Charnay P. Ebf gene function is required for coupling neuronal differentiation and cell cycle exit. Development 2003, 130:6013-6025.
12. Garel S., Marin F., Mattei M.G., Vesque C., Vincent A., Charnay P. Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn 1997, 210:191-205.
13. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999, 96:10911-10916.
14. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
15. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998, 26:362-367.
16. Honda M., Eriksson K.S., Zhang S., Tanaka S., Lin L., Salehi A., Hesla P.E., Maehlen J., Gaus S.E., Yanagisawa M., Sakurai T., Taheri S., Tsuchiya K., Honda Y., Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One 2009, 4:e4254.
17. Hubbard T.J., Aken B.L., Ayling S., Ballester B., Beal K., Bragin E., Brent S., Chen Y., Clapham P., Clarke L., Coates G., Fairley S., Fitzgerald S., Fernandez-Banet J., Gordon L., Graf S., Haider S., Hammond M., Holland R., Howe K., Jenkinson A., Johnson N., Kahari A., Keefe D., Keenan S., Kinsella R., Kokocinski F., Kulesha E., Lawson D., Longden I., Megy K., Meidl P., Overduin B., Parker A., Pritchard B., Rios D., Schuster M., Slater G., Smedley D., Spooner W., Spudich G., Trevanion S., Vilella A., Vogel J., White S., Wilder S., Zadissa A., Birney E., Cunningham F., Curwen V., Durbin R., Fernandez-Suarez X.M., Herrero J., Kasprzyk A., Proctor G., Smith J., Searle S., Flicek P. Ensembl 2009. Nucleic Acids Res 2009, 37:D690-D697.
18. Jimenez M.A., Akerblad P., Sigvardsson M., Rosen E.D. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol Cell Biol 2007, 27:743-757.
19. Kieslinger M., Folberth S., Dobreva G., Dorn T., Croci L., Erben R., Consalez G.G., Grosschedl R. EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev Cell 2005, 9:757-767.
20. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
21. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
22. Lu J.W., Fenik V.B., Branconi J.L., Mann G.L., Rukhadze I., Kubin L. Disinhibition of perifornical hypothalamic neurones activates noradrenergic neurones and blocks pontine carbachol-induced REM sleep-like episodes in rats. J Physiol 2007, 582:553-567.
23. Malgaretti N., Pozzoli O., Bosetti A., Corradi A., Ciarmatori S., Panigada M., Bianchi M.E., Martinez S., Consalez G.G. Mmot1, a new helix-loop-helix transcription factor gene displaying a sharp expression boundary in the embryonic mouse brain. J Biol Chem 1997, 272:17632-17639.
24. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
25. Mieda M., Willie J.T., Hara J., Sinton C.M., Sakurai T., Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004, 101:4649-4654.
26. Moriguchi T., Sakurai T., Takahashi S., Goto K., Yamamoto M. The human prepro-orexin gene regulatory region that activates gene expression in the lateral region and represses it in the medial regions of the hypothalamus. J Biol Chem 2002, 277:16985-16992.
27. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
28. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
29. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
30. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6:991-997.
31. Radulovacki M., Virus R.M., Djuricic-Nedelson M., Green R.D. Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 1984, 228:268-274.
32. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
33. Scammell T.E., Willie J.T., Guilleminault C., Siegel J.M. A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 2009, 32:111-116.
34. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
35. Thannickal T.C. A decade of hypocretin/orexin: accomplishments in sleep medicine. Sleep Med Rev 2009, 13:5-8.
36. Tsujino N., Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009, 61:162-176.
37. Wang H.L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 2009, 29:340-358.
38. Wang M.M., Reed R.R. Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast. Nature 1993, 364:121-126.
39. Wang M.M., Tsai R.Y., Schrader K.A., Reed R.R. Genes encoding components of the olfactory signal transduction cascade contain a DNA binding site that may direct neuronal expression. Mol Cell Biol 1993, 13:5805-5813.
40. Wang S.S., Tsai R.Y., Reed R.R. The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development. J Neurosci 1997, 17:4149-4158.
41. Wang S.S., Lewcock J.W., Feinstein P., Mombaerts P., Reed R.R. Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection. Development 2004, 131:1377-1388.
42. Williams R.W., Rakic P. Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol 1988, 278:344-352.
43. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., Leonard C.S., Richardson J.A., Hammer R.E., Yanagisawa M. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
44. Yang H.S., Vitaterna M.H., Laposky A.D., Shimomura K., Turek F.W. Genetic analysis of daily physical activity using a mouse chromosome substitution strain. Physiol Genomics 2009, 39:47-55.